Olema Pharmaceuticals, Inc.
OLMA
DELAYED 1 MONTH
2 insider filings · Latest: Jul 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Jul 27 11:30 PM | Cyrus HarmonDirector | Sale | 12,500 | $11.71 | $146.4K | 702,770(D) | View → |
| Jul 23, 2026 | Jul 27 11:30 PM | Cyrus HarmonDirector | Sale | 12,500 | $11.58 | $144.7K | 715,270(D) | View → |
| Mar 4, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Sale | 25,000 | $24.25 | $606.4K | 0(D) | View → |
| Mar 3, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Sale | 15,000 | $23.01 | $345.1K | 0(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 25,000 | $4.37 | 410,000(D) | View → |
| Mar 3, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 15,000 | $4.37 | 435,000(D) | View → |